Source: Annual Congress 2011 - Growth factors and fibrogenesis: are they good, bad or both?
Disease area: Interstitial lung diseases



Rating:

Share or cite this content

Citations should be made in the following way:
E. McGrath, H. Marriott, A. Lawrie, S. Cross, P. Mercer, P. Hellewell, R. Chambers, D. Dockrell, M. Whyte (Sheffield, London, United Kingdom). The role of TNF-related apoptosis inducing ligand (TRAIL) in fibrotic lung disease. Eur Respir J 2011; 38: Suppl. 55, 3231

Member's Comments

No comment yet.

Related content which might interest you: Role of TNF-related apoptosis inducing ligand (TRAIL) in lung protective immunity against S. pneumoniae Source: Annual Congress 2010 - Mechanisms of respiratory infections Year: 2010 Enhanced expression of Fas ligand (FasL) in fibrotic interstitial lung diseases (ILDs). The possible role of membrane-bound FasL form Source: Annual Congress 2011 - Genetic and molecular background in pulmonary fibrosis Year: 2011 Fas Ligand (FasL) expressed on alveolar lymphocytes (AL) plays role in progression of interstitial lung diseases (ILD) but not in local induction of immune cells apoptosis Source: Eur Respir J 2005; 26: Suppl. 49, 542s Year: 2005 Effects of chemotherapeutic drugs and TRAIL (tumor necrosis factor-related apoptosis inducing ligand) on the non-small lung cancer cells Source: Annual Congress 2009 - Treatment of lung cancer Year: 2009 Alveolar recruited macrophages contribute to lung epithelial apoptosis and barrier dysfunction by expression of TNF-related apoptosis-inducing ligand during influenza virus pneumonia Source: Annual Congress 2008 - Border patrol: the alveolar barrier in lung injury Year: 2008 Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) Source: Annual Congress 2009 - Diagnosis and treatment of lung cancer Year: 2009 Gemcitabine sensitizes lung cancer cells to Fas /Fas ligand system-mediated killing Source: Annual Congress 2011 - Treatment of lung cancer Year: 2011 Macrophage released TNF-related apoptosis-inducing ligand (TRAIL) impairs alveolar fluid clearance after Influenza A virus infection Source: Lung Science Conference 2015 Year: 2015 Oral presentation: Mesenchymal stem cells reduce lung metastases by controlled targeted delivery of TNF-related apoptosis-inducing ligand (TRAIL) Source: Lung Science Conference 2009 - Cell proliferation, Differentiation and Carcinogenesis Year: 2009 TRAIL and Bax-mediated apoptosis, pathways by which apoptosis may be induced in emphysema Source: Eur Respir J 2006; 28: Suppl. 50, 824s Year: 2006 Resistance to Fas-mediated apoptosis in human lung fibroblast Source: Eur Respir J 2002; 20: 359-368 Year: 2002 A role for soluble Fas ligand in neutrophil/epithelial cell apoptosis in Wegener‘s granulomatosis? Source: Annual Congress 2007 - Recent advances in the understanding of lung injury and repair Year: 2007 Expression and function of Fas receptor (CD95) and Fas ligand (FasL) on T cells in atopic bronchial asthma (ABA): the role of glucocorticoid (GC)-therapy Source: Eur Respir J 2005; 26: Suppl. 49, 581s Year: 2005 Inhibition of proliferation of lung cancer cells by CD40 signaling through tumor necrosis factor I Source: Annual Congress 2008 - Biology and prognosis in thoracic oncology Year: 2008 Resistance of BAL immune cells to apoptosis in interstitial lung diseases (ILD) with high local tumor necrosis factor-α (TNFα) levels as a possible consequence of common TNF receptor type 2 expression Source: Annual Congress 2008 - Role of bronchoalveolar lavage in studying the pathophysiology of interstitial lung disease Year: 2008 The death receptor CD95 (Fas, Apo-1) expression and Annexin-V binding of phosphatidylserine in lymphocytes in bronchial asthma patients Source: Eur Respir J 2006; 28: Suppl. 50, 757s Year: 2006 Fas activation impairs the alveolar epithelial function in mice by mechanisms involving apoptosis Source: Annual Congress 2011 - Anti-inflammatory strategies in acute lung injury Year: 2011 Expression and clinical importance of Fas/Fas ligand system in interstitial lung diseases (ILD) Source: Eur Respir J 2006; 28: Suppl. 50, 745s Year: 2006 Interferon-gamma (IFN-γ) alters the expression of IP-10 and IL-18 in human aveolar epithelial cells type II. Possible role in the reinforcement of Th1-dominated lung inflammation Source: Eur Respir J 2001; 18: Suppl. 33, 521s Year: 2001